Advertisement

Vaginal Cancer

  • Serah Choi
  • Tracy Sherertz
Chapter

Abstract

This chapter will discuss the clinical presentation, pathology, staging, management, and radiation techniques for primary vaginal cancers.

Keywords

Primary vaginal cancers Vaginal carcinoma Vaginal intraepithelial neoplasia (VAIN) 

Notes

Acknowledgment

We thank Thomas T. Bui MD, Eric K. Hansen MD, and Joycelyn L. Speight MD, PhD for their work on the prior edition of this chapter.

References

  1. Alonso I, Felix A, Torné A, et al. Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina. Gynecol Oncol. 2012;125(1):194–9.CrossRefPubMedGoogle Scholar
  2. Beriwal S, Demanes DJ, Erickson B, et al. American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. Brachytherapy. 2012;11(1):68–75.CrossRefPubMedGoogle Scholar
  3. Beriwal S, Heron DE, Mogus R, et al. High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina. Radiat Oncol. 2008;3:7.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Chyle V, Zagars GK, Wheeler JA, et al. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys. 1996;35:891–905.CrossRefPubMedGoogle Scholar
  5. de Crevoisier R, Sanfilippo N, et al. Exclusive radiotherapy for primary squamous cell carcinoma of the vagina. Radiother Oncol. 2007;85(3):362–70.CrossRefPubMedGoogle Scholar
  6. Edge SB, American Joint Committee on Cancer. American Cancer Society. AJCC cancer staging manual. 7th ed. New York: Springer Science+Business Media; 2010.Google Scholar
  7. Feldbaum VM, Flowers LC, Oprea-Ilies GM. Improved survival in p16-positive vaginal cancers across all tumor stages but no correlation with MIB-1. Am J Clin Pathol. 2014;142(5):664–9.CrossRefPubMedGoogle Scholar
  8. Frank SJ, Deaver MT, Jhingran A, et al. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol. 2007;105(2):470–4.CrossRefPubMedGoogle Scholar
  9. Frank SJ, Jhingran A, Levenback C, et al. Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys. 2005;62:138–47.CrossRefPubMedGoogle Scholar
  10. Frumovitz M, Gayed IW, Jhingran A, et al. Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol. 2008;108(3):478–81.CrossRefPubMedGoogle Scholar
  11. Gardner CS, Sunil J, Klopp AH, et al. Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. BJR. 2015;88(1052):20150033–11.CrossRefPubMedGoogle Scholar
  12. Green S, Stock RG. Cancer of the vagina. In: Leibel SA, Phillips TL, editors. Textbook of radiation oncology. 3rd ed. Philadelphia: Saunders; 2010. p. 1067–84.CrossRefGoogle Scholar
  13. Harris EE, Latifi K, Rusthoven C, Javedan K, Forster K. Assessment of organ motion in postoperative endometrial and cervical cancer pts treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011;81(4):e645–50.CrossRefPubMedGoogle Scholar
  14. Huh WK, Straughn JM Jr, Mariani A, et al. Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience. Int J Gynecol Cancer. 2007;17(4):886–9.CrossRefPubMedGoogle Scholar
  15. Jhingran A, Salehpour M, Sam M, Levy L, Eifel PJ. Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy. Int J Radiat Oncol Biol Phys. 2012;82(1):256–62.CrossRefPubMedGoogle Scholar
  16. Joura EA, Leodolter S, Hernandez-Avila M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet. 2007;369(9574):1693–702.CrossRefPubMedGoogle Scholar
  17. Kang J, Viswanathan AN. Vaginal Cancer. In: Perez CA, Brady LW, Halperin EC, et al., editors. Principles and practice of radiation oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1465–501.Google Scholar
  18. Klopp AH, Eifel PJ, Berek JS, Konstantinopoulous PA. Cancer of the cervix, vagina, and vulva. In: DeVita Jr VT, Lawrence TS, Rosenberg SA, editors. DeVita, Hellman, and Rosenberg’s cancer principles & practice of oncology. 10th ed. Philadelphia: Wolters Kluwer Health; 2015. p. 1013–47.Google Scholar
  19. Lian J, Dundas G, Carlone M, Ghosh S, Pearcey R. Twenty-year review of radiotherapy for vaginal cancer: an institutional experience. Gynecol Oncol. 2008;111(2):298–306.CrossRefPubMedGoogle Scholar
  20. Miyamoto DT, Viswanathan AN. Concurrent chemoradiation for vaginal cancer. PLoS One. 2013;8(6):e65048.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Morris M, Blessing JA, Monk BJ, et al. Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol. 2004;22(16):3340–4.CrossRefPubMedGoogle Scholar
  22. Nag S, Yacoub S, Copeland LJ, Fowler JM. Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer pts. Int J Radiat Oncol Biol Phys. 2002;54:1153–9.CrossRefPubMedGoogle Scholar
  23. National Cancer Institute. Vaginal Cancer (PDQ): Treatment. 2016. Available at: http://www.cancer.gov/types/vaginal/hp/vaginal-treatment-pdq. Accessed on 15 Aug 2016.
  24. Orton A, Boothe D, Williams N, et al. Brachytherapy improves survival in primary vaginal cancer. Gynecol Oncol. 2016;141(3):501–6.CrossRefPubMedGoogle Scholar
  25. Platta CS, Anderson B, Geye H, Das R, Straub M, Bradley K. Adjuvant and definitive radiation therapy for primary carcinoma of the vagina using brachytherapy and external beam radiation therapy. J Contemp Brachytherapy. 2013;2:76–82.CrossRefGoogle Scholar
  26. Perez CA, Grigsby PW, Garipagaoglu M, et al. Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys. 1999;44:37–45.CrossRefPubMedGoogle Scholar
  27. Rajagopalan MS, Xu KM, Lin JF, Sukumvanich P, Krivak TC, Beriwal S. Adoption and impact of concurrent chemoradiation therapy for vaginal cancer: a National Cancer Data Base (NCDB) study. Gynecol Oncol. 2014;135(3):495–502.CrossRefPubMedGoogle Scholar
  28. Russell AH, Horowitz NS. Vulvar and vaginal carcinoma. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 4th ed. Philadelphia: Churchill Livingstone; 2015. p. 1230–63.Google Scholar
  29. Samant R, Lau B, Choan E, et al. Primary vaginal cancer treated with concurrent chemoradiation using cis-platinum. Int J Radiat Oncol Biol Phys. 2007;69:746–50.CrossRefPubMedGoogle Scholar
  30. Stock RG, Chen AS, Seski J. A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities. Gynecol Oncol. 1995;56(1):45–52.CrossRefPubMedGoogle Scholar
  31. Tran PT, Su Z, Lee P, et al. Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation. Int J Radiat Oncol Biol Phys. 2006;S66:1052.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations